The push by Eli Lilly and Co. will come despite an unfavorable ruling last week from Medicare that sharply restricts reimbursements for a drug in the same class.
CEO Jeff Simmons’ goal is to make Indianapolis “an epicenter of animal health innovation.” While a bold goal, Simmons has proven he is a bold leader who prioritizes the growth of his company, as well as the community.
Acacia Pharma Group employees are waiting to see what will happen to their jobs and whether the company will remain in Indianapolis in any form, now that it is being acquired by New Jersey-based specialty drugmaker Eagle Pharmaceuticals Inc. for $103.9 million.
When it comes to competing for jobs, Indiana is far behind the curve in critical ways, Eli Lilly and Co. CEO David Ricks told a lunch crowd Wednesday at the Economic Club of Indiana.
The imaging agent is the six-year-old company’s first commercial launch, following millions of dollars’ worth of research and clinical tests. It was approved by the U.S. Food and Drug Administration in December.
The drug, called tirzepatide, has been closely watched by medical professionals and is viewed by financial analysts as possible blockbuster, with potential annual sales in the billions of dollars.
Eli Lilly and Co. posted profit of $1.9 billion in the first quarter, up 40%, on higher sales of COVID-19 antibodies and other key products for diabetes, cancer and arthritis.
While discussions about opportunities for improvement are important, they should also be framed in context of relative strengths. Indiana is strong and getting stronger.
The following is a partial transcript of Ricks’ speech to the Economic Club of Indiana on April 20, in which he spoke about problems in Indiana’s business climate.
David Ricks called on government for help fix Indiana’s business climate. I think we will have to do more—a lot more. State government simply lacks the technological sophistication, budgetary discipline and political consensus to do enough.
David Ricks’ lunchtime speech to The Economic Club of Indiana—repeated on social media by those in attendance and reported by IBJ and local TV stations—has reverberated across the state.
Local tech-industry executives say an expansion of an existing investor tax-credit program, plus an increased emphasis on high-school computer education, would go a long way to help support the state’s tech sector.
A panel of Indiana life science experts on Friday said the state could become more competitive for large investments and jobs if it doubled down on the kind of collaborations and partnerships that other states have used to their advantage.
We suggest a more comprehensive approach to making Indiana the best place in the U.S. to do business. That means more intense focus on why workers would want to be here, how we can keep more college grads in the state, and how to encourage greener energy sources.
When the CEO of Eli Lilly and Co. provides direct feedback as to why high-paying jobs that could have come to Indiana did not, we all should take note.
The pharmaceutical giant is turning heads with an experimental medicine it claims can help obese patients shed nearly a quarter of their body weight and manage diabetes.
The development team behind a hotel planned for a parcel across from Shapiro’s Delicatessen in downtown Indianapolis is adding about 60 apartments to the mix, as well as a rooftop restaurant.
Our top two priorities should be strengthening Indiana’s teacher preparation programs and enrolling more high school graduates in post-secondary education.
